Related references
Note: Only part of the references are listed.Targeting docetaxel-PLA nanoparticles simultaneously inhibit tumor growth and liver metastases of small cell lung cancer
Zhen Liang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
In vivo studies: comparing the administration via and the impact on the biodistribution of radiopharmaceuticals
Suyene Rocha Pinto et al.
NUCLEAR MEDICINE AND BIOLOGY (2014)
Radiolabelled nanohydroxyapatite with 99mTc: perspectives to nanoradiopharmaceuticals construction
Marta de Souza Albernaz et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2014)
Neutron-Activatable Holmium-Containing Mesoporous Silica Nanoparticles as a Potential Radionuclide Therapeutic Agent for Ovarian Cancer
Anthony J. Di Pasqua et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement
S. Guiu et al.
ANNALS OF ONCOLOGY (2012)
Tumor accumulation of neutron-activatable holmium-containing mesoporous silica nanoparticles in an orthotopic non-small cell lung cancer mouse model
Anthony J. Di Pasqua et al.
INORGANICA CHIMICA ACTA (2012)
Aptamers and the next generation of diagnostic reagents
Varatharasa Thiviyanathan et al.
PROTEOMICS CLINICAL APPLICATIONS (2012)
Aptamer in Bioanalytical Applications
Anton B. Iliuk et al.
ANALYTICAL CHEMISTRY (2011)
Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study
Jens Huober et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
227 Pharmacokinetic and biodistribution studies of anti MUC1 PEGylated aptamers with potential in the targeted radiotherapy of breast cancer
C. Leite Diniz et al.
EJC SUPPLEMENTS (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Paclitaxel-Loaded Polymeric Micelles Modified with MCF-7 Cell-Specific Phage Protein: Enhanced Binding to Target Cancer Cells and Increased Cytotoxicity
Tao Wang et al.
MOLECULAR PHARMACEUTICS (2010)
Aptamers as therapeutics
Anthony D. Keefe et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
An overview of prognostic factors for long-term survivors of breast cancer
Isabelle Soerjomataram et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Drug therapy: Trastuzumab - Mechanism of action and use in clinical practice
Clifford A. Hudis
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
